Advances in adult pulmonary tuberculosis

Current Opinion in Pulmonary Medicine

Volumn 8, Issue 3, 2002, Pages 173-177

  Maartens, Gary ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

BCG VACCINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; REVIEW; SPUTUM ANALYSIS;

EID: 0036110362     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200205000-00004     Document Type: Review

References (44)

1. The latent tuberculosis bacillus (I'll let you know if I ever meet one)
2. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection
3. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions
4. A novel mycolic acid cyclopropane synthetase is required for cording, persistence and virulence of Mycobacterium tuberculosis
5. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
6. Microbial pathogenesis of Mycobacterium tuberculosis: Dawn of a discipline
7. Can eradication of worms change the face of AIDS and tuberculosis?
8. Effect of deworming on human T-cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination
9. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
10. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis
11. What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence?
12. Dual pulmonary infection with MycobacteriuM. tuberculosis and Pneumocystis carinii in patients infected with human immunodeficiency virus
13. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV
14. Diagnosing tuberculosis in a resource-poor setting: The value of sputum concentration
15. Diagnosing tuberculosis in a resource-poor setting: The value of sputum concentration
16. Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus
17. The use of sputum induction for establishing a diagnosis in patients with suspected tuberculosis in Malawi
18. Yield of smear, culture and amplification tests from repeated sputum induction for the diagnosis of pulmonary tuberculosis
19. False-positive growth of Mycobacterium tuberculosis attributable to laboratory contamination confirmed by restriction fragment length polymorphism analysis
20. False diagnosis of tuberculosis
21. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10
22. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in the Gambia
23. Depressed T-cell interferon-gamma production responses in pulmonary tuberculosis: Analysis of underlying mechanisms and modulation with therapy
24. Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania
25. A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area
26. High-compliance tuberculosis treatment program in a rural community
27. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase
28. Substandard tuberculosis drugs on the global market and their simple detection
29. In vivo veritas: The search for TB drug targets goes live
30. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis
31. Low failure rate in standardized retreatment of tuberculosis in Nicaragua: Patient category, drug resistance and survival of "chronic" patients
32. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant Mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines
33. Late complications of collapse therapy for pulmonary tuberculosis
34. Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan
35. Concurrent infections and HIV pathogenesis
36. Impact of pulmonary tuberculosis on survival of HIV-infected adults: A prospective epidemiologic study in Uganda
37. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area
38. Accelerated course of human immunodeficiency virus infection after tuberculosis
39. Effect of preventive treatment for tuberculosis in adults infected with HIV: Systematic review of randomized placebo controlled trials
40. Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil
41. Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials
42. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults
43. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults
44. HIV-associated tuberculosis in the era of highly active antiretroviral therapy